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ABSTRACT
Selenocysteine (Sec) is referred to as the 21st proteogenic amino acid and is found
in place of the redox-sensitive amino acid cysteine (Cys) in a small number of proteins.
Sec and Cys carry out similar chemistry and are structural isomers save for a single atom
difference; the former contains selenium (Se), while the latter contains sulfur (S) in the
identical position. Sec poses a high bioenergetic cost for its synthesis and subsequent
incorporation into protein not shared by Cys. Since Sec’s discovery in 1976, scientists
have debated why certain proteins express Sec while others express Cys. In recent years,
it has been shown that redox-active enzymes expressing Sec exhibit a distinct biological
advantage over their Cys-containing counterparts. Sec-containing enzymes retain their
catalytic activities when exposed to highly oxidizing conditions, while analogous Cyscontaining enzymes become significantly inactivated.
This thesis examines the enzyme thioredoxin reductase (TrxR), an essential
regulator of cellular redox homeostasis. TrxR is expressed in higher-order organisms
such as humans and other mammals with a penultimate Sec residue in its C-terminal
redox center, while lower-order organisms such as Drosophila melanogaster (D.
melanogaster) express TrxR with Cys. Using spectrophotometric activity assays, we
show that the presence of Sec preserves thioredoxin reductase’s ability to reduce its
canonical substrate, thioredoxin (Trx), in the presence of hydrogen peroxide. Herein, we
use mass spectrometry analysis to provide a biophysical basis for this phenomenon
through the characterization and quantitation of the TrxR’s two redox centers that drive
its mechanism of action. Our findings show that Sec confers superior resistance to
oxidation-induced inactivation not because Sec better resists irreversible hyperoxidation
but instead TrxR’s redox centers to better retain their reductive abilities. In D.
melanogaster’s Cys-containing TrxR, we show that a significant loss of its redox center’s
reductive ability coincides with the loss of its enzymatic activity.
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Chapter 1: SELENOCYSTEINE: THE 21st
AMINO ACID
1.1 SELENIUM IN BIOLOGY
Elemental selenium was discovered in 1817 by the Swedish chemist Jöns Jacob
Berzelius as a by-product of sulfuric acid production 1. Scientists initially believed
selenium to be an environmental toxin after observing that livestock given plant feed
containing high selenium levels developed health defects 2. It was not until 1957 that
Schwarz and coworkers first demonstrated selenium’s beneficial role when administering
low concentrations of selenium prevented liver necrosis in rats 3. Long since Schwarz’s
early work, selenium is now considered an essential micronutrient obtained through diet
3-5

. Deficiency in dietary selenium results in numerous health maladies, including cancer,

type-II diabetes, seizures, and cardiovascular impairment 6-10. Severe selenium deficiency
manifests in several human diseases, notably Keshan disease, Kashin-Beck disease, and
Myxedematous endemic cretinism 11-13.
Although trace amounts of selenium occur in various organic and inorganic forms, it
is primarily incorporated in proteins as selenocysteine (Sec, U) which is considered the
21st proteinogenic amino acid 14, 15. Structurally, Sec is an analog of the amino acid
cysteine (Cys, C), as shown in Figure 1, but differs in its composition by a single atom
substitution; Sec contains selenium (Se) in place of the sulfur (S) atom found in cysteine.
Both sulfur and selenium are nonmetal chalcogens belonging to group 16 of the periodic
table and exhibit similar physical and chemical properties. Nevertheless, despite their
similarities, sulfur and selenium endow Cys and Sec with different biochemical
1

characteristics. While Cys occurs ubiquitously in protein, Sec occurs in a small handful
of proteins due to selenium’s low natural abundance and significantly more complex and
bioenergetically demanding synthesis and incorporation. Given the initial cost of Sec
incorporation, scientists question what evolutionary advantage drives some proteins to
use Sec instead of Cys.

Figure 1. Structures of selenocysteine and cysteine. Both amino acids are structural
analogs differing in a single atom substitution; selenocysteine contains selenium (Se) in
place of cysteine’s sulfur (S).

Although relatively rare, proteins containing Sec exist sporadically across all the
kingdoms of life. However, current analyses indicate that occurrences of selenoproteins
are more prevalent in higher-order eukaryotes such as mammals. Interestingly, for the
selenoproteins identified thus far, different kingdoms do not share common
selenoproteins; orthologs containing Cys exist for every known selenoprotein 16. To date,
scientists only know of thirty-four Sec residues and twenty-five unique selenoproteins in
humans, listed in Table 1. Concurrently, the human genome encodes roughly 214,000
cysteine residues 17. This thesis focuses on the selenoprotein thioredoxin reductase
2

(TrxR), which plays an essential role in maintaining cellular redox homeostasis via the
reduction of its canonical substrate, thioredoxin (Trx) 18. When expressed in mammals,
TrxR expresses a Cys-Sec dyad in its substrate-binding C-terminal redox center, yet the
TrxR ortholog from D. melanogaster expresses a Cys-Cys dyad in its C-terminal redox
center. Both the Sec- and Cys-containing TrxRs catalyze the reduction of their substrates
by way of a nicotinamide adenine dinucleotide phosphate (NADPH)-dependent electron
transfer pathway in which the availability of reduced Cys and Sec residues in the Cterminal redox site is vital for their catalytic activity 19, 20. Ultimately, this thesis aims to
provide a biophysical basis for understanding the evolutionary advantage of Sec
incorporation and to corroborate previous observations that Sec-containing TrxRs retain
their thioredoxin reductase activity better than their Cys-orthologs under oxidizing
conditions as a direct result of the presence of selenium.

3

Table 1. Human selenoproteins and their known functions.
Protein

Function

Glutathione peroxidase (GPx) family members
GPx1
GPx2
GPx3
GPx4
GPx6

Cytosolic glutathione peroxidase
Gastrointestinal glutathione peroxidase
Plasma glutathione peroxidase
Phospholipid hydroperoxide glutathione
peroxidase
Olfactory glutathione peroxidase

Thioredoxin reductase (TrxR) family members
TrxR1
TrxR2
TrxR3

Reduction of cytosolic thioredoxin
Reduction of mitochondrial thioredoxin
Reduction of testis-specific thioredoxin

Iodothyronine deiodinases (DIO) family
DIO1

Thyroid hormone-activating iodothyronine
deiodinase
Tissue-specific thyroid hormone-activating
iodothyronine deiodinase
Tissue-specific thyroid hormone-activating
iodothyronine deiodinase

DIO2
DIO3

Se-protein 15 and M Family
SelM
Sep15

Unknown
Putative role in quality control of protein folding
in the ER

Se-protein S and K family
SelS
SelK

Putative role in ER-associated degradation
Putative role in ER-associated degradation

Rdx proteins family
SelW
SelH
SelT
SelV

Unknown
Unknown
Unknown
Unknown

Other selenium-containing proteins
SelP
SPS2
SelR
SelN
SelI
SelO

Selenium transport
Involved in the synthesis of selenoproteins
Reduction of oxidized methionine residues
Putative role during muscle development
Unknown
Unknown

4

1.2 PROPERTIES OF CYSTEINE AND SELENOCYSTEINE
1.2.1 Similarities Between Sulfur and Selenium
Sulfur and selenium are nonmetal chalcogens belonging to group 16 of the
periodic table. With the same number of valence electrons, both elements adopt a similar
range of oxidation states, including fractional states from -2 to +6, enabling both Cys and
Sec to exist in many chemically unique forms 21, 22. In protein, sulfur and selenium act as
strong nucleophiles capable of attacking electrophiles including alkylating agents,
reactive oxygen species (ROS), and reactive nitrogen species (RNS) 23, 24. As such, Cys,
Sec, and other chalcogen-containing amino acids, including methionine (Met) and
tyrosine (Tyr), exhibit redox biochemistry 25.

1.2.2 Differences Between Sulfur and Selenium
While sulfur and selenium belong to the same periodic group and exhibit similar
chemistry, Cys and Sec possess nonidentical physiochemical properties resulting from
the presence of selenium and sulfur. One of the most distinguishing physical features
contributing to Cys and Sec’s differing properties is the difference in selenium’s and
sulfur’s atomic radii. Selenium exhibits an atomic radius of 115 pm, while sulfur has a
radius of 100 pm 26. The longer radius of selenium results in a weaker attractive force
between its nucleus and the electrons in its outer valance shell, making selenium “softer”
and more polarizable than sulfur. As a softer atom, selenium forms bonds that are longer
and require less energy to form and break than the analogous bonds to sulfur. For
example, hydrogen bonding with selenium is considerably weaker than with sulfur, and
the resulting selenols (R-SeH) are considerably more acidic and labile at physiological
5

pH than sulfur-containing thiols (R-SH). Accordingly, the pKa of free Sec is substantially
lower than that of free Cys (5.25 vs. 8.3), making Sec’s selenol group on its side chain a
better leaving group at physiological pH.
Additionally, Sec favors the formation of a reactive selenolate anion (R-Se-) while
Cys favors the formation of the stabler protonated thiol 14, 27. Thus, Sec is more reactive
than Cys at physiological pH, as exemplified by the significant difference between their
selenol/diselenide exchange and thiol/disulfide exchange rate constants. Pleasants and
coworkers observe that diselenide bonds have weaker bond energies than disulfide bonds
(46 kcal*mol-1 vs. 64 kcal*mol-1) and that selenol/diselenide exchange exhibits a rate
constant 1.2*107 times greater than thiol/disulfide exchange at physiological pH 28.
As a more polarizable atom, selenium acts as both a stronger nucleophile and a
more robust electrophile than sulfur 27. Hondal observes that the nucleophilic attack rates
at physiologically relevant pHs are faster for selenium than sulfur; at a pH of 5,
selenium’s rate of nucleophilic attack is ~1000 times greater than sulfur and ~10 times
greater at pH 8 29. Besides providing Sec with faster and more thermodynamically
favorable bond formation and degradation energies, selenium’s electrophilic character
enables the formation of more stable hypervalent species. Since it is better able to tolerate
additional electrons, selenium processes a significantly more negative redox potential
than sulfur (E0 = -488 mV vs. normal hydrogen electrode (NHE) for Sec; E0 = -233 mV
vs. NHE for Cys) 25. Sec’s more negative redox potential favors the reduction of oxidized
targets and the formation of low oxidation state Sec products; the biological significance
of this is discussed further in Section 2.4.
6

1.2.3 Mechanism for Selenocysteine Synthesis and Incorporation
The mechanism by which cells synthesize Sec and incorporate it into protein is a
bioenergetically costly process that distinguishes it from all other amino acids. A cell will
fully synthesize the twenty standard amino acids before aminoacylation occurs onto their
transfer ribonucleic acid (tRNA). Next, the ribosomal A-site recruits the charged tRNA
molecules, where a unique anticodon aligns with a codon triplicate sequence on the
messenger ribonucleic acid (mRNA) unique for each amino acid. Finally, the amino acid
ligates onto the expanding polypeptide at the ribosomal P-site.
Sec, by contrast, is synthesized directly on its tRNA molecule and requires
additional molecular machinery to decode its codon in the mRNA sequence from a
“nonsense” codon to a “sense” codon. Generally read as the “opal” termination codon for
a growing polypeptide, Sec incorporation requires the reinterpretation of its
corresponding codon, UGA 30. Biosynthesis of selenocysteine begins with the adenosine
triphosphate (ATP)-dependent aminoacylation of L-serine onto tRNA[Ser]Sec by the
enzyme seryl-tRNA synthase (SERS) 31, 32. Next, a phosphate group replaces serine’s
hydroxyl group via phosphoseryl-tRNA kinase (PTSK) forming O-phosphoseryl-tRNASec
(Sep-tRNASec) in an ATP-dependent reaction 33. The enzyme O-phosphoseryltRNA:selenocystenyl-tRNA synthase then proceeds to replace the phosphate group with a
selenide group derived from a selenophosphate donor forming selenocystenyl-tRNASec 34.
Prior to this step, selenite and ATP react with the enzyme selenophosphate synthase 2
(SPS2) to produce the selenophosphate donor, monoselenophosphate 35.

7

Following the co-translational synthesis of selenocystenyl-tRNASec, organisms
require additional cellular factors to decode the mRNA nonsense codon UGA to
incorporate Sec onto a growing polypeptide (see Figure 2). To interpret UGA as a sense
codon, an mRNA motif known as the Sec insertion sequence (SECIS) element must be
present downstream of the UGA codon in the 3’ untranslated region 36, 37. The SECIS
element binds to SECIS binding protein-2 (SBP2) which then recruits a selenocysteine
elongation factor (EFSec). EFSec binds to the selenocystenyl-tRNASec, completing a
quaternary complex capable of decoding the UGA codon 38. Following the formation of
the quaternary complex, selenocystenyl-tRNASec migrates to the ribosomal A-site, where
the aminoacylated Sec residue couples to a growing polypeptide chain in the ribosomal
P-site, completing its incorporation 39.

Figure 2. Quaternary complex involved in selenocysteine incorporation. The complex
consists of a selenocysteine insertion sequence (SECIS, blue) in 3’ untranslated region of
mRNA, SECIS binding protein-2 (SPB2, orange), elongation factor Sec (EFSEC), and
tRNASec (purple). This structure enables the decoding of the UGA nonsense codon
(black) as a sense codon for selenocysteine incorporation.

8

1.3 WHY NATURE CHOSES SELENOCYSTEINE
To date, all selenoproteins found in nature also have known Cys-containing orthologs
17, 40-45

. While scientists agree that Sec must provide some biological advantage to justify

its atypical and costly incorporation, they contest the specific advantage conferred by
selenium’s presence. In the past, scientists attributed differences in nucleophilicity, pKa,
and electrophilicity between Sec and Cys as possible explanations of why nature goes out
of its way to use selenium (via Sec) instead of sulfur (via Cys) in select proteins.
In Sec-containing proteins such as mammalian thioredoxin reductase (mTrxR),
research shows that Sec plays an essential role in mTrxR’s catalytic activity 46. Zhong
and Holmgren observe that a Sec→Cys mutant preserves mTrxR’s ability to reduce Trx,
but the resulting enzymatic activity significantly diminishes. They conclude that a
significant loss of reductase activity illustrates Sec’s role in boosting catalysis due to its
nucleophilicity relative to Cys due to having a lower pKa value. Despite showing
increased catalytic rates, the differences in nucleophilicities between sulfur and selenium
are modest and do not typically exceed more than a six to tenfold difference 47, 48. As
such, it is improbable that a modicum improvement in nucleophilicity explains the
selective pressure for Sec’s incorporation. This hypothesis also fails to justify Sec’s
incorporation in the presence of widely available means to lower the pKa of Cys thiol
groups achievable by adjusting the local protein microenvironment 49, 50. Researchers
have documented numerous occurrences of Cys pKa depression, capable of making Cys’s
pKa comparable to that of Sec’s through various stabilizing forces 51-54.

9

Another prevailing model is that the differences in Sec’s and Cys’s pKa values enable
Sec’s selenol group to act as a better leaving group than cysteine’s thiol group, which
then acts to enhance a selenoenzyme’s catalytic activity 55, 56. At a pKa value ~5.2, by
comparison to Cys’s pKa value of ~8.3, Sec’s selenol group is considerably more acidic
than the average thiol and thus acts as a better leaving group 14, 54. This model proposes
that selenium serves as a better electron acceptor and can better drive reactions dependent
on electron exchange. However, this model does not explain why TrxR performs electron
exchanges with the selenium-containing substrate selenite (SeO32-) but not sulfurcontaining sulfite (SO32-) despite neither molecule possessing leaving groups with low
pKa values 55.

1.3.1 The electrophilic character of selenocysteine helps selenoproteins
resist oxidative inaction
While selenium’s electrophilic character is well documented, its biochemical
significance has mainly gone unnoticed. As a more electrophilic atom, selenium can
better accept additional electrons and stabilize hypervalent states than sulfur. Although
selenium’s nucleophilic character enables Sec-containing compounds to readily oxidize,
these oxidized forms also reduce more easily than oxidized sulfur species. The cycling of
oxidized and reduced Cys and Sec species is illustrated in Figure 3 57-59. For enzymes
whose activities are contingent upon the presence of sulfur or selenium species residing
in the reduced form, hyperoxidation of these atoms to the point where they are
nonreducible leads to a loss of enzyme function 60, 61. The seminal work of Chaudière and
coworkers first describes the occurrence of Sec-dependent resistance to oxidation10

induced inactivation. Chaudière observes that Sec-containing glutathione peroxidase
(GPX) retains activity in the presence of hydrogen peroxide (H2O2) while the Cyscontaining GPX mutant becomes inactivated under the same conditions 62.

Figure 3. Cycling of oxidized and reduced selenium-containing and sulfur-containing
species. Oxidation of a selenol (SeH) group to selenenic acid (SeOH) or seleninic acid
(SeO2-) species quickly revert to reduced selenol. Formation of selenonic acid (SeO3-) is
irreversible. The oxidation of a thiol (SH) group to sulfonic acid (SOH) is reversible (less
so than selenenic acid). In contrast, the formation of either sulfinic acid (SO2-) or sulfonic
acid (SO3-) is irreversible.

Similarly, Hondal and coworkers observe resistance to irreversible hyperoxidation in
the Sec-containing mTrxR but not in its Cys-ortholog, DmTrxR 63. Likewise, Conrad and
colleagues demonstrate that in the presence of increased cellular H2O2, mammalian
11

interneuron cells containing wild-type Sec-GPX survive while those containing a
Sec→Cys mutation are highly sensitive to hyperoxide-induced ferroptosis 64. Conrad’s
analysis using mass spectrometry reveals a 31-fold increase in the number of oxidized
Cys species in the Cys-GPX mutant following exposure to 100 µM H2O2. Such findings
suggest that selenoenzymes evolved to resist the deleterious effects of oxidative stress
and that Sec plays an essential role in the redox regulation of cell signaling of other
selenoproteins in addition to GPX 65.

1.4 THIOREDOXIN-THIOREDOXIN REDUCTASE
SYSTEM
Thioredoxin reductase (TrxR) is a homodimeric pyridine nucleotide oxidoreductase
chiefly responsible for regulating cellular redox homeostasis. TrxR provides reducing
equivalents to downstream cellular targets via the reduction of its canonical substrate,
thioredoxin (Trx) 66. Two distinct forms of TrxR exist with related yet distinct catalytic
pathways; higher-order eukaryotes express high-molecular weight (Mr) TrxRs, while
prokaryotes, archaea, plants, and lower-order eukaryotes express low-Mr TrxRs 60, 67, 68. A
critical distinction between the two forms of TrxRs is the number of redox centers present
and involved in catalysis. While low-Mr TrxRs contain a flavin adenine dinucleotide
(FAD) cofactor and N-terminal redox center, high-Mr TrxRs contain a FAD cofactor, an
N-terminal redox center, and an additional C-terminal redox center. Despite differing in
their amino acid compositions and catalytic mechanisms, all TrxRs reduce their
respective substrates through an NADPH-dependent transfer of electrons 69. Within the

12

C-terminal redox center of high-Mr TrxRs, a penultimate Sec residue resides in the TrxRs
of humans and other mammals such as that of Mus muscarines (mTrxR).
Lower-order organisms express high-Mr TrxRs containing dual cysteine residues in
their C-terminal redox centers such as in D. melanogaster TrxR (DmTrxR). The
structural similarities between mTrxR and DmTrxR are shown in Figure 4 and Figure 5,
respectively. Under normal physiological conditions, Sec- and Cys-containing TrxRs
exhibit comparable Trx reductase activities with their own endogenous Trx substrates,
indicating that Sec is nonessential for the reduction of Trx’s disulfide 70. Furthermore,
mutagenesis experiments show that Sec’s replacement with Cys in the C-terminal redox
center does not prevent substrate reduction, although doing so results in a lower kcat and
higher KM 46, 61. Sec’s beneficial role becomes apparent in the presence of oxidizing stress
during which Sec-TrxR retains its catalytic efficiency, and the analogous Cys-TrxR
reductase activity diminishes significantly 63.

13

Figure 4. Mammalian thioredoxin reductase (mTrxR) structure.

14

Figure 5. Drosophila melanogaster thioredoxin reductase (DmTrxR) structure.

1.4.1 General Function
TrxRs comprise an enzyme family that directly maintains the redox state of their
primary substrate, Trx, by reducing an active site disulfide bond using reducing
equivalents donated from NADPH (see Figure 6) 66, 69. Together, TrxR, Trx, and
NADPH comprise the thioredoxin/thioredoxin reductase system, one of two major
cellular antioxidant systems – the other being the glutathione/glutaredoxin/glutathione
reductase (GR) system 71. Through the reduction of Trx, TrxR effectively regulates many
downstream cellular redox processes. Trx regulates the redox states of biomolecules
involved in numerous cellular biochemical processes by reducing disulfides in “Trx-fold”
15

proteins – proteins named for the characteristic “Cys-X-Y-Cys” motif (where X and Y
are variable amino acids other than Cys) 72. Such proteins function in essential processes
such as oxidant scavenging (ex: thioredoxin peroxidase), DNA synthesis (ex:
ribonucleotide reductase (RNR)), tumor suppression (ex: p53), protein phosphorylation
(ex: protein tyrosine phosphatase 1B (PTP1B)), protein disulfide formation (ex: disulfide
bond protein A (DsbA)), protein repair (ex: methionine-R-sulfoxide reductase 1B
(MsrB1)), and apoptosis regulation (ex: apoptosis signal-regulating kinase 1 (ASK1)) 73.
In the event of TrxR inactivation, an imbalance of redox regulation leads to increases in
pro-oxidant activity. Further oxidative stress results in impaired cellular function,
increased lipid peroxidation, protein degradation, nucleic acid decomposition, and cell
death 71, 74.

16

Figure 6. Thioredoxin (Trx)/thioredoxin reductase (TrxR) antioxidant system. TrxR
catalyzes the reduction of oxidized Trx disulfides through the transfer of reducing
equivalent donated by NADPH. Once reduced, Trx reduces disulfide bonds of other
“Trx- fold” proteins to regulate several redox-sensitive biochemical processes.

1.4.2 Two forms of TrxRs
TrxR enzymes exist in two distinct forms, which follow similar, yet nonidentical
catalytic pathways 67, 68, 75, 76. Found in prokaryotes, archaea, plants, and lower
eukaryotes, low-Mr TrxRs contain two 35 kDa subunits. In higher-order eukaryotes such
as mammals, high-Mr TrxRs contain two 55 kDa subunits, previously illustrated. All
TrxRs subunits arrange themselves in a “head-to-tail” orientation in which the Cterminus of one subunit juxtaposes the N-terminus of the opposing subunit. Each subunit
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contains a bound flavin adenine dinucleotide (FAD) cofactor molecule and an N-terminus
redox center. High-Mr TrxRs also contain a third C-terminal redox center 67, 68, 75. For
both low-Mr and high-Mr TrxRs, the N-terminus redox center contains a conserved -CysX-X-X-Cys- motif, where “X” is any amino acid other than Cys, a motif common to all
oxidoreductases 77. Another critical distinction between the two forms of TrxRs is the
presence of a highly mobile 16 amino acid residue C-terminal tail containing the Cterminal redox center 78. C-terminal redox centers vary in their composition and may
contain dual Cys residues, as is the case for DmTrxR’s Ser-Cys-Cys-Ser (SCCS)
tetrapeptide or both a Cys and Sec residue, as is in mTrxR’s tetrapeptide Gly-Cys-SecGly (GCUG).

1.4.3 High-Mr Thioredoxin Reductase Mechanism of Action
TrxR catalyzes the reduction of oxidized disulfide bonds belonging to its
canonical substrate, Trx, via an NADPH-dependent transfer of reducing equivalents 69.
The mechanism by which high-Mr TrxR catalyzes this process proceeds in a multistep
transfer of hydride ions and electrons, outlined in Figure 7, for Sec-containing mTrxR
(top panel) and Cys-containing DmTrxR (bottom panel). First, NADPH donates hydride
(H-) ions to each FAD cofactor molecule adjacent to the N-terminal domain of TrxR,
forming FADH2. Next, FADH2 transfers a hydride to the N-terminal redox center on the
same dimer subunit, reducing the Cys-S-S-Cys disulfide linkage and oxidizing FADH2
back to FAD. The two resulting Cys-thiols then reduce the opposing subunit’s C-terminal
redox center Cys-S-S-Cys disulfide (for DmTrxR) or Cys-S-Se-Sec selenylsulfide (for
mTrxR) bobds, reforming the N-terminal Cys-S-S-Cys disulfide. The reduction of the C18

terminal selenylsulfide in TrxRs favors the attack of the Sec residue over the adjacent
Cys residue due to selenium’s robust electrophilic character. Attack of Sec occurs far
more rapidly than the reduction of analogous dual-cysteine disulfide 28, 79. The final step
concludes with the transfer of electrons from the C-terminal redox center to reduce Trx’s
disulfide bond and the reloading of the C-terminal disulfide or selenylsulfide bond. Due
to selenium’s nucleophilic character, Sec’s selenolate anion (Sec-Se-) initiates the attack
of Trx’s disulfide 60. Once reduced, Trx reduces disulfide bonds on “Trx-fold” proteins
such as those previously mentioned in Section 1.4.1.

Figure 7. Mechanistic overview of mTrxR and DmTrxR. The top mechanism illustrates
the NADPH-dependent redox cycling of mammalian thioredoxin reductase’s FAD
cofactor, N-terminal redox center, and C-terminal redox center resulting in the reduction
of a Trx disulfide. The bottom mechanism illustrates the analogous NADPH-dependent
redox cycling pathway of DmTrxR's FAD cofactor, N-terminal redox center, and Cterminal redox center resulting in the reduction of a Trx disulfide.

1.4.4 Oxidation of Thioredoxin Reductase
Scientists agree that TrxR plays a critical antioxidant role in maintaining cellular
redox homeostasis 80. As stated earlier, the thiol and selenol groups on Cys and Sec are
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prime targets for reactions with ROS and reactive electrophile species (RES). Within the
cell, TrxRs encounter intracellular oxidants, including H2O2, hypochlorous acid (HOCl),
hypobromous acid (HOBr), hydroxyl radicals (·OH), peroxynitrite (NO3-),
hypothiocyanous acid (HOSCN), amongst others 63. The presence of intracellular
oxidants leads to the direct oxidation of selenol and thiol groups and inhibits Trxdependent cellular pathways 81. Hondal and coworkers observe decreases in Trx
reductase activity for both Sec- and Cys-containing TrxRs in the presence of various
intracellular oxidants, although the latter group is significantly more inhibited 63.
These observations support Chaudière and coworkers’ hypothesis that
selenocysteine is responsible for the resistance of hyperoxidation-induced enzyme
inactivation in the selenoenzyme glutathione peroxidase 62, 64, 82. Hondal and Ruggles
note that because selenium’s electrophilic character is more robust than sulfur’s, Seoxides reduce more quickly than analogous S-oxides. As such, oxidation of selenol is
more reversible than the same oxidation state of a thiol, and is especially true at higher
oxidation states 83. Figure 8 provides an overview of the general mechanism for the
reduction of oxidized Cys and Sec residues. While a Cys-thiol (Cys-SH) can be oxidized
to sulfenic acid (Cys-SOH) and reduced back, further oxidation to sulfinic acid (CysSO2H) and sulfonic acid (Cys-SO3H) is irreversible. Sec-selenols (Sec-SeH), on the other
hand, oxidize to selenenic acid (Sec-SeOH) or seleninic acid (Sec-SeO2H) and then
quickly reduce back. However, in the presence of sufficient oxidant, they can oxidize
irreversibly to selenonic acid (Sec-SeO3H). Both sulfonic and selenonic acids are subject
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to β-elimination, in which oxidized sulfur and selenium act as leaving groups, producing
dehydroalanine (DHA).
In the following chapter, this work explores Sec’s role in conferring resistance to
oxidation-induced inactivation in the selenoenzyme mTrxR by comparing its response to
its Cys-ortholog, DmTrxR. Herein, we use liquid chromatography-mass spectrometry
(LCMS) to directly measure the occurrence of oxidative post-translational modifications
(PTMs) in both mTrxR’s and DmTrxr’s N- and C-terminal redox centers under oxidizing
conditions. The identification and quantitation of modifications corresponding to redox
centers in “Reduced,” “Bridge,” and “Hyperoxidized” states serve as the basis for
explaining selenium’s ability to maintain its mechanism of action under oxidizing
conditions.
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Figure 8. Oxidative modification and repair of cysteine and selenocysteine. The top
mechanism illustrates the oxidation pathway of a reduced cysteine thiol group to
reducible sulfenic acid and further oxidation to the irreversibly hyperoxidized sulfinic
and sulfonic acids. β-elimination of sulfonic acid leads to the formation of
dehydroalanine (DHA). The bottom mechanism illustrates the oxidations pathway of a
reduced selenocysteine selenol group to reducible selenenic or seleninic acids and further
oxidation to the irreversibly hyperoxidized selenonic acid. β-elimination of selenonic acid
leads to the formation of DHA.
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Chapter 2: ASSESSING THE ABILITY OF SECTRXR TO RESIST OXIDATION-INDUCED
INACTIVATION
2.1 INTRODUCTION
This chapter discusses two sets of experiments aimed to (1) compare the relative
change of mammalian mTrxR and D. melanogaster DmTrxR thioredoxin reductase
activities in the presence of increasing H2O2 using spectrophotometry and (2) employ
LCMS to qualitatively and quantitatively evaluate molecular changes undergone by both
enzymes under assay conditions and in vivo conditions. The Hondal laboratory has
achieved the first aim, and trends observed in this work are in close agreement with
previous findings 63, 84. LCMS experiments by Conrad successfully identified and
quantified oxidative modifications of the Sec residue of the selenoenzyme glutathione
peroxidase (GPX). However, our work describes a method that enables the formation of
mechanistic insights by comprehensively measuring hyperoxidation and evaluating the
reductive abilities of TrxR’s N- and C-terminal redox centers.
Conrad and colleagues’ findings give rise to the prediction that hyperoxidation of
TrxR’s C-terminal redox center results in the loss of reductase activity. Initially, we use
spectrophotometric assays to indirectly measure the amount of substrate, Escherichia coli
(E. coli) Trx, reduced by wild-type DmTrxR and mTrxR. Although the actual activities
are known to differ for both enzymes with E. coli Trx, we report relative changes in each
enzyme’s activity in the presence of H2O2. In these assays, we monitor relative enzyme
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activity by measuring NADPH consumption, which is proportional to the amount of E.
coli Trx substrate reduced.
Concurrent with our spectrophotometric activity assays, we use LCMS analysis
to identify TrxR enzyme N- and C-terminal redox centers in their modified chemical
states under various oxidative conditions. A label-free quantitation technique integrates
and extracts areas under the curve from detected species’ mass chromatograms. One set
of LCMS experiments examines samples oxidized in the absence of substrate to mimic
the activity assay oxidative conditions. Later, we employ LCMS to analyze samples
oxidized in the presence of E. coli Trx to reflect in vivo conditions.
Since the ability to reduce Trx depends on TrxR’s ability to successfully transfer
reducing equivalents from NADPH to its N-terminal redox center, to its C-terminal redox
center, and eventually to Trx, we report the relative abundances of species corresponding
to the Hyperoxidized, Reduced, and oxidized Bridge states of mTrxR’s and DmTrxR’s
redox centers. Due to the reactive nature of TrxR’s Reduced species, we use the
alkylating agent iodoacetamide (IAM) to cap them with a stable carbamidomethyl group
(CAM), preventing side chemistry. We evaluate activity changes attributed to increases
in irreversible hyperoxidation and losses in redox center reductive abilities by examining
percentage shifts for all three states. These strategies compare the variable responses of
both mTrxR and DmTrxR to changes in concentration of H2O2 (at 0 mM, 1 mM, and 20
mM) and the effect of withholding or introducing reducible substrate at the time of
oxidizing stress.
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2.2 METHODS
Trx activity assay: H2O2 knockdown of TrxRs. Stock solutions of H2O2 were freshly
prepared in deionized water (ddI H2O) before experimentation, and the solution
concentration was determined by taking a static absorbance reading at 240 nm on a Cary
50 UV/VIS spectrophotometer at 22 °C and calculated using Beer’s Law using a
pathlength of 1 cm and an extinction coefficient of 43.6 M-1cm-1. NADPH was previously
prepared in ddI H2O to a concentration of 20 mM and frozen in aliquots before use. For
each assay, 150 µL reactions were generated in triplicate for samples containing either 25
nM wild-type mTrxR or 400 nM wild-type DmTrxR. Enzymes were brought up in 100
mM potassium phosphate (KP), 1 mM ethylenediaminetetraacetic acid (EDTA), pH 7.0
buffer, and pre-reduced with 200 µM NADPH at 22 °C for 5 min. Next, samples were
administered either ddI H2O (for controls), 1 mM H2O2, or 20 mM H2O2 and gently
shaken on an orbital shaker for 25 min at 22 °C. 50 µL of catalase-bound agarose beads
was mixed into each sample and gently shaken for an additional 15 min at 22 °C to
degrade any remaining oxidant. Next, each sample was transferred to a 2.0 mL Costar®
Spin-X centrifuge tube filter and centrifuged at 3,000 x g for 4 min at 22 °C. The
resulting flowthrough was then collected and transferred to a quartz 80 µL volume
cuvette. Samples were reduced a second time with 200 µM NADPH, and the background
absorbance slope was measured at 340 nm for 2 min using a Cary 50 UV/VIS
spectrophotometer at 22 °C. Following this, each enzyme assay was initiated by adding
50 µM E. coli Trx, and the absorbance slope was measured at 340 nm for 2 min. For each
assay, activity slopes were corrected by subtracting the initial background slope and then
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averaged. Corrected activity slopes were then compared to the average slope of the
control samples to calculate the percentage of thioredoxin reductase activity remaining.
H2O2 knockdown of TrxRs preceding LCMS. Inactivation of TrxR enzymes was
conducted in the presence of increasing concentrations of H2O2 (0-20 mM) preceding
tryptic digestion and subsequent MS analysis. 500 µL reactions containing 15 µg of
either mTrxR wild-type (400 nM) or DmTrxR wild-type (400 nM) were prepared in 50
mM ammonium bicarbonate (AmBic), 1 mM EDTA, pH 8 buffer at room temperature
(22 °C). TrxR enzymes were pre-reduced with 200 µM NADPH for 5 min. Next, either
50 µM E. coli Trx or the equivalent volume of ddI H2O was added to each sample,
followed by the immediate addition of oxidant (0, 1, or 20 mM H2O2). Samples were then
placed on an orbital shaker for 25 min. After shaking, the reaction mixtures were
transferred to 30 kDa molecular weight cutoff Amicon® Ultra 0.5 mL centrifugal filter
tubes and centrifuged at 13,000 min-1 for 4 min at 22°C to remove excess oxidant. Flowthrough was discarded, and the resulting concentrate was washed with 250 µL of 50 mM
AmBic, 1 mM EDTA, pH 8 buffer. Ultrafiltration and washing were repeated twice more
before a final ultrafiltration step. The resulting concentrate was then collected and
pipetted into a 1.5 mL microcentrifuge tube followed by digestion.
Trypsin digestion of TrxRs. After exposure to oxidizing conditions, TrxR enzymes were
cleaved into their constituent tryptic peptides. Concentrated 15 µg samples of wildtype
mTrxR and DmTrxR treated with H2O2, as described previously, were placed into a
SpeedVac where the suspension buffer was evaporated. Once dry, samples were
resuspended in 75 µL of 0.1% RapiGest™ SF surfactant prepared in ddI H2O. Next,
26

samples were placed in a 37°C water bath for 1 h. Next,10 mM IAM was prepared in
fresh 50 mM AmBic, pH 7.8 buffer, and then pipetted into each sample to a final
concentration of 1 mM. Samples were alkylated by placing them in the dark at 22°C for
30 min. Next, 25 µL of thawed 0.1 µg/µL trypsin in 50 mM AmBic, pH 7.8 buffer was
added to each sample and gently vortexed for 30 seconds. Samples were tightly wrapped
in parafilm and placed in a 37°C water bath for 18 h to digest overnight. The following
day, samples were retrieved and dried down in a SpeedVac. The digestion process was
arrested by resuspending samples in 100 µL of 7% formic acid (FA) in ddI H2O and then
placed into a 37°C water bath for 1 h. Samples were dried once more in a SpeedVac and
resuspended in 100 µL of 0.1% trifluoroacetic acid (TFA) prepared in ddI H2O. Upon
resuspension, samples were placed into a 37 °C water bath for 1 h. Finally, samples were
centrifuged at 14,000 min-1 for 5 min at 4 °C, and the top 95 µL of each sample was
collected and transferred to MS sample vials.
LCMS general method. A total of 3 µg of digested protein sample (~150 pg/µL) was
injected onto a Waters X-select HSST3 (3.5 µm, 1.0 x 150 mm) liquid chromatography
column at a flow rate of 0.1 mL/min. A 78-minute LC gradient was used with mobile
phase A containing 0.1% FA in ddI H2O and mobile phase B containing 0.1% FA in
acetonitrile (ACN). From 0.0 to 4.0 min, mobile phase B was held at 3%. From 4.0 to
44.0 min, mobile phase B was raised linearly to 40%. From 44.0 to 48.0 min, mobile
phase B was raised to 60%. From 48.0 to 52.0 min, mobile phase B was held at 60%.
From 52.0 to 58.0 min, mobile phase B was dropped to 3%. Finally, from 58.0 to 78.0
min, mobile phase B was held at 3%. Samples were ionized by electrospray ionization
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(ESI) on a Thermo Q ExactiveTM mass spectrometer where full MS scans were performed
at a resolution of ~70,000 in positive ion mode. Collected raw data chromatograms and
spectra were then analyzed manually using Xcalibur Qual Browser V3.
Analysis of TrxR N- and C-terminal redox site peptides by MS. Before analysis,
theoretical trypsin digests were performed for truncated mitochondrial Mus muscarines
thioredoxin reductase 2 (mTrxR, DOI: 10.2210/pdb3DGZ/pdb) with the terminal trimer
H-Cys-Sec-Gly-OH (CUG) manually added to the FASTA file and wild-type
mitochondrial Drosophila melanogaster thioredoxin reductase 1 (DmTrxR, DOI:
10.2210/pdb3DH9/pdb) using the online ExPASy Peptide Mass toolkit. Theoretical m/z
values were determined for the reduced redox site-containing peptides for the DmTrxR
N-terminal WGVGGTCVNVGCIPK65 (745.37 m/z), DmTrxR C-terminal
SGLDPTPASCCS491 (1,137.46 m/z), mTrxR N-terminal WGLGGTCVNVGCIPK61
(752.37 m/z), and mTrxR C-terminal SGLEPTVTGCUG491 (1,171.42 m/z) peptides. For
each peptide, theoretical m/z values were calculated to reflect mass shifts relative to
reduced Cys-thiol and Sec-selenol species, consistent with oxidized and alkylated
modifications on each peptide’s two redox-active residues. For each redox-active residue,
theoretical m/z peptide values were determined for carbamidomethylated species (+57.02
amu per modified residue), oxidation to sulfenic or selenenic acid (+15.99 amu per Cys
or Sec), oxidation to sulfinic or seleninic acid (+31.98 amu per Cys or Sec), oxidation to
sulfonic or selenonic acid (+47.97 amu per Cys or Sec), β-elimination of Cys to DHA (32.98 amu per Cys), β-elimination of Sec to DHA (-80.92 amu per Sec), and intrapeptide
disulfide or selenylsulfide bonds (-2.01 amu per residue pair). Additionally, theoretical
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m/z values were determined for each peptide accounting for modifications in which Cys
and Sec residues were simultaneously oxidized and alkylated. Using Xcalibur Qual
Browser V3, mass spectra from extracted ion chromatograms corresponding to each
modified peptide were generated using predicted m/z values and then manually verified.
For each identification, a mass tolerance of ±0.05 atomic mass units (amu) was used in
addition to manual evaluation of predicted isotope pattern distribution and theoretical ion
charge. Identified peptide species were subsequently categorized as being “Reduced,”
oxidized to the disulfide or selenylsulfide “Bridge” form or oxidized to one of various
irreversible “Hyperoxidized” forms.
Quantification of peptide modifications: mass balance analysis. All quantification was
performed using Xcalibur Qual Browser V3 with 3-point Boxcar automatic smoothing
enabled following previously described methods 85. Extracted ion chromatograms (EIC)
were generated using the full m/z range of an identified species’ observable isotopic
envelope. The “add peaks” feature was then used, the area of the corresponding
chromatographic peak was selected, and the area under the curve was extracted to an
Excel worksheet for further workup. To account for variations in sample amounts
between each sample, raw area values for each sample were normalized by dividing each
value by the average of five reference peptide areas determined not to be altered by the
variable administered treatment conditions. Reference peptides were chosen on the basis
of the following criteria: they consistently produced raw areas greater than or equal to 1.0
e+9 on average, did not contain Cys and Sec residues, and were not detected with
oxidation modifications or missed cleavages. For DmTxR, the peptides SILVR223 (587.39
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m/z), GIPFLR246 (702.43 m/z), TVPLSVEK255 (872.51 m/z), LLVK264 (472.35 m/z), and
LAITK478 (545.37 m/z) were chosen. For mTrxR, the peptides VQLQDR117 (379.71 m/z),
YFNIK125 (684.38 m/z), ASFVDEHTVR135 (580.79 m/z), TLNEK296 (771.42 m/z), and
AGISTNPK304 (394.22 m/z) were chosen. Once normalized, detected PTM areas
corresponding to each single peptide were summed to calculate the normalized “total
peptide area” for each sample. Next, areas of modified states were grouped as
Hyperoxidized, Reduced, or Bridge and summed for each sample. The percentage of each
modification type was calculated by dividing the normalized total modification type area
total by the normalized total peptide area for each sample. Once the percentage of each
modification type was determined, the average was taken across three biological
replicates (n=3). The change in the percentage of each modification type between the
control (0 mM H2O2) and highest treatment concentration (20 mM H2O2) was calculated
by subtracting the former from the latter.

2.3 RESULTS
Data presented herein reflects N- and C-terminal redox center-containing peptide
species detected for DmTrxR and mTrxR listed in Table 2 and Table 3, respectively, by
probing mass spectra for predictable mass shifts associated with possible Cys and Sec
modifications (see Table 4). For all the detected forms of DmTrxR’s and mTrxR’s Nterminal and C-terminal redox centers, the corresponding mass spectra and chemical
structures appear in Appendix B.
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Table 2. Full MS digest of wildtype mTrxR.
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Table 3. Full MS digest of wildtype DmTrxR.
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Table 4. Cysteine and selenocysteine modifications.
Modification

Abbreviation

Structure

Δ Mass
(amu)

Thiol / Selenol

Red

R-SH / R-SeH

+0.00

Carbamidomethyl

CAM

R-S-CH2CONH2 /
R-Se-CH2CONH2

+57.02

Disulfide / Selenosulfide

Bridge

R-S-S-R / R-S-Se-R

-2.02

Sulfenic / Selenenic Acid

Ox

R-SOH / R-SeOH

+15.99

Sulfinic / Seleninic Acid

Diox

R-SO2H / R-SeO2H

+31.98

Sulfonic / Selenonic Acid

Triox

R-SO3H / R-SeO3H

+47.97

Cysteine→Dehydroalanine

Cys→DHA

R=CH2

-32.98

Selenocysteine→Dehydroalanine

Sec→DHA

R=CH2

-80.92

2.3.1 Spectrophotometric thioredoxin reductase activity assays
Data generated from spectrophotometric activity assays for both the Sec-enzyme
mTrxR and its Cys-ortholog DmTrxR show the responses to increasing concentrations of
H2O2 on E. coli Trx reductase activity (see Table 5 & Figure 9). It should be noted that
in the absence of H2O2, mTrxR, which contains Sec, displays 16-fold higher Trxreductase activity than DmTrxR, which contains Cys (25 nM mTrxR vs. 400 nM
DmTrxR used). In the presence of 1 mM H2O2, DmTrxR retains 55% of its initial
thioredoxin reductase activity, while the mTrxR sample retains 93% of its initial
thioredoxin reductase activity. In the presence of 20 mM H2O2, DmTrxR activity
diminishes further to 29%, while the mTrxR retains 88% of its initial reductase activity.
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Table 5. Percentage of E. coli Trx reductase activity remaining after H2O2 knockdown.
0 mM H2O2

1 mM H2O2

20 mM H2O2

Δ0→20 (%)

mTrxR

100%

92%

88%

-12%

DmTrxR

100%

55%

29%

-71%

Figure 9. H2O2 knockdown of TrxR E. coli thioredoxin reductase activities. Percent
remaining Trx reductase activity shown for wild-type mammalian thioredoxin reductase
(mTrxR; red) and wild-type drosophila thioredoxin reductase (DmTrxR; blue) at 0-20
mM H2O2. Error bars reflect standard deviation across three biological replicants.

2.3.2 Detection of DmTrxR redox centers in the absence of E. coli Trx
In the control digest with E. coli Trx and H2O2 present, we detect DmTrxR’s Nterminal redox peptide WGVGGTCVNVGCIPK65 in the CAM+CAM (802.39 m/z),
CAM+CAM+Diox (818.39 m/z), CAM+CAM+Triox (826.39 m/z), CAM+Diox (789.87
m/z), CAM+Triox (797.87 m/z), CAM+Cys→DHA (756.88 m/z), and Bridge (744.36
m/z) forms. At 1 mM H2O2, no change in detected N-terminal modifications occurs.
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However, with 20 mM H2O2, we detect a novel Triox+Triox (793.35 m/z) modification.
See Table 6 for all DmTrxR N-terminal redox center species.
Table 6. Detected forms of DmTrxR N-terminal redox center.
WGVGGTCVNVGCIPK

m/z

Modification type

Reduced

745.37

Reduced

CAM+Red

773.88

Reduced

CAM+CAM

802.39

Reduced

CAM+Diox

789.87

Hyperoxidized

CAM+Triox

979.87

Hyperoxidized

CAM+Cys→DHA

756.88

Hyperoxidized

Diox+Triox

785.35

Hyperoxidized

Triox+Cys→DHA

752.36

Hyperoxidized

Bridge

744.36

Bridge

We report the subsequent quantitation of each detectable DmTrxR N-terminal
redox center modification in Table 7 and graph the resulting data in Figure 10. Our data
reveals that DmTrxR’s N-terminal redox site initially exhibits 54% Reduced species,
42% Bridge species, and 4% Hyperoxidized species. At 1 mM H2O2, we detect the Nterminal redox center with 40% Reduced species, 57% Bridge species, and 3%
Hyperoxidized species. At 20 mM H2O2, we see 25% Reduced species, 71% Bridge
species, and 3% Hyperoxidized species. Our data shows that between 0 mM and 20 mM
H2O2, Reduced species decrease by 29%, Bridge species increase by 30%, and
Hyperoxidized species decrease by 1%.
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Table 7. DmTrxR N-terminal redox center response to H2O2 knockdown in the absence
of E. coli Trx.
WGVGGTCVNVGCIPK 0 mM H2O2

1 mM H2O2 20 mM H2O2

Δ0→20 (%)

Reduced

54%

40%

25%

-29%

Bridge

42%

57%

71%

+30%

Hyperoxidized

4%

3%

3%

-1%

Figure 10. DmTrxR N-terminal redox center response to H2O2 in the absence of E. coli
Trx. Change in percentage of Bridge (blue), Reduced (orange), and Hyperoxidized (grey)
species shown in the presence of 0, 1, and 20 mM H2O2. Error bars show standard
deviation.
In the absence of E. coli Trx and H2O2, DmTrxR’s C-terminal peptide
SGLDPTPASCCS491 occupies the Reduced (1137.46 m/z), CAM+CAM (1251.50 m/z),
CAM+CAM+Diox (1283.50 m/z), CAM+CAM+Triox (1299.50 m/z), CAM+Diox
(1226.47 m/z), CAM+Triox (1242.46 m/z), CAM+Cys→DHA (1160.49 m/z),
36

Diox+Triox (1217.43 m/z), Triox+Triox (1233.42 m/z), and Bridge (1135.44 m/z) forms.
Following the addition of 1 mM H2O2, we do not detect any additional species. Like the
N-terminal redox center, the addition of 20 mM H2O2 results in the detection of the Cterminal Triox+Triox (1233.42 m/z) modification. All DmTrxR C-terminal redox center
species are summarized in Table 8.
Table 8. Detected forms of DmTrxR C-terminal redox center.
SLGDPTPASCCS

m/z

Modification type

CAM+CAM

1,251.50

Reduced

CAM+CAM+Diox

1,283.50

Hyperoxidized

CAM+Diox

1,226.47

Hyperoxidized

CAM+Triox

1242.46

Hyperoxidized

CAM+Cys→DHA

1,160.49

Hyperoxidized

Diox+Triox

1,217.43

Hyperoxidized

Triox+Triox

1,233.42

Hyperoxidized

Triox+Cys→DHA

1,151.49

Hyperoxidized

Bridge

1,135.44

Bridge

We report quantitative data on DmTrxR’s C-terminal redox center in Table 9 and
graph the resulting data in Figure 11. In the absence of E. coli Trx and H2O2, DmTrxR’s
C-terminal redox center exhibits 25% Reduced species, 69% Bridge species, and 7%
Hyperoxidized species. At 1 mM H2O2, we detect 28% Reduced species, 67% Bridge
species, and 5% Hyperoxidized species. At 20 mM H2O2, our data shows 13% Reduced
species, 70% Bridge species, and 16% Hyperoxidized species. Between 0 mM and 20
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mM H2O2, we observe a 12% decrease in Reduced species, a 1% increase in Bridge
species, and a 9% increase in Hyperoxidized species.
Table 9. DmTrxR C-terminal redox center response to H2O2 knockdown in the absence
of E. coli Trx.
SLGDPTPASCCS

0 mM H2O2

1 mM H2O2 20 mM H2O2

Δ0→20 (%)

Reduced

25%

28%

13%

-12%

Bridge

69%

67%

70%

+1%

Hyperoxidized

7%

5%

16%

+9%

Figure 11. DmTrxR C-terminal redox center response to H2O2 in the absence of E. coli
Trx. Change in percentage of Bridge (blue), Reduced (orange), and Hyperoxidized (grey)
species shown in the presence of 0, 1, and 20 mM H2O2. Error bars show standard
deviation.
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2.3.3 Detection of mTrxR redox centers in the absence of E. coli Trx
In the absence of E. coli Trx and H2O2, we detect mTrxR’s N-terminal redox
peptide WGLGGTCVNVGCIPK61 in its CAM+Red (780.88 m/z), CAM+CAM (809.40
m/z), CAM+Triox (804.88 m/z), CAM+Cys→DHA (763.89 m/z), and Bridge (751.37
m/z) forms. At 1 and 20 mM H2O2, no change in detectable N-terminal species occurs.
All detected mTrxR N-terminal redox center species are listed in Table 10.
Table 10. Detected forms of mTrxR N-terminal redox center.
WGLGGTCVNVGCIPK

m/z

Modification type

CAM+Red

780.88

Reduced

CAM+CAM

809.40

Reduced

CAM+CAM+Diox

825.40

Hyperoxidized

CAM+Diox

796.88

Hyperoxidized

CAM+Triox

804.88

Hyperoxidized

CAM+Cys→DHA

763.89

Hyperoxidized

Diox+Triox

792.36

Hyperoxidized

Bridge

751.37

Bridge

We report the subsequent quantitation of each detectable mTrxR N-terminal redox
center modification in Table 11 and graph the resulting data in Figure 12. Our data
reveals that mTrxR’s N-terminal redox site initially exhibits 27% Reduced species, 70%
Bridge species, and 3% Hyperoxidized species in the absence of H2O2 and E. coli Trx. At
1 mM H2O2, we detect the N-terminal redox center as 19% Reduced species, 77% Bridge
species, and 4% Hyperoxidized species. At 20 mM H2O2, we see 20% Reduced species,
73% Bridge species, and 7% Hyperoxidized species. Between 0 mM and 20 mM H2O2,
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we observe a 7% decrease in Reduced species, a 4% increase in Bridge species, and a 4%
increase in Hyperoxidized species.
Table 11. mTrxR N-terminal redox center response to H2O2 knockdown in the absence of
E. coli Trx.
WGLGGTCVNVGCIPK 0 mM H2O2

1 mM H2O2 20 mM H2O2

Δ0→20 (%)

Reduced

27%

19%

20%

-7%

Bridge

70%

77%

73%

+4%

Hyperoxidized

3%

4%

7%

+4%

Figure 12. mTrxR N-terminal redox center response to H2O2 in the absence of E. coli
Trx. Change in percentage of Bridge (blue), Reduced (orange), and Hyperoxidized (grey)
species shown in the presence of 0, 1, and 20 mM H2O2. Error bars show standard
deviation.
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In the absence of E. coli Trx and H2O2, we detect mTrxR’s C-terminal peptide
SGLEPTVTGCUG491 in the Reduced (1171.42 m/z), CAM+Red (1228.44 m/z),
CAM+CAM (1285.46 m/z) CAM+CAM+Diox (1317.46 m/z), CAM+Cys→DHA
(1194.45 m/z), CAM+Sec→DHA (1146.51 m/z), and Bridge (1169.40 m/z) forms
Following the addition of 1 or 20 mM H2O2, we do not detect any additional species. A
complete list of all detected mTrxR C-terminal redox center species is provided in Table
12.
Table 12. Detected forms of mTrxR C-terminal redox center.
SLGEPTVTGCUG

m/z

Modification type

CAM+CAM

1,285.46

Reduced

CAM+CAM+Diox

1,317.46

Reduced

CAM+CAM+Triox

1,333.46

Hyperoxidized

CAM+Diox

1,260.43

Hyperoxidized

CAM+Triox

1,276.42

Hyperoxidized

CAM+Cys→DHA

1,194.45

Hyperoxidized

CAM+Sec→DHA

1,146.51

Hyperoxidized

Bridge

1,169.40

Bridge

We report summarizes quantitative data on mTrxR’s C-terminal redox center in
Table 13 and graphed in Figure 13. In the absence of E. coli Trx and H2O2, mTrxR’s Cterminal redox center exhibits 88% Reduced species, 6% Bridge species, and 6%
Hyperoxidized species. At 1 mM H2O2, we detect 86% Reduced species, 4% Bridge
species, and 10% Hyperoxidized species. At 20 mM H2O2, our data shows 26% Reduced
species, 4% Bridge species, and 30% Hyperoxidized species. Between 0 mM and 20 mM
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H2O2, we see a 62% decrease in Reduced species, a 38% increase in Bridge species, and
a 24% increase in Hyperoxidized species.
Table 13. mTrxR C-terminal redox center response to H2O2 knockdown in the absence of
E. coli Trx.
SLGEPTVTGCUG

0 mM H2O2 1 mM H2O2 20 mM H2O2

Δ0→20 (%)

Reduced

88%

86%

26%

-62%

Bridge

6%

4%

44%

+38%

Hyperoxidized

6%

10%

30%

+24%

Figure 13. mTrxR C-terminal redox center response to H2O2 in the absence of E. coli
Trx. Change in percentage of Bridge (blue), Reduced (orange), and Hyperoxidized (grey)
species shown in the presence of 0, 1, and 20 mM H2O2. Error bars show standard
deviation.
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2.3.4 Detection of DmTrxR redox centers in the presence of E. coli Trx
Following the addition of 50 µM E. coli Trx and H2O2, we detect DmTrxR’s Nterminal redox peptide WGVGGTCVNVGCIPK65 in the Reduced (745.37 m/z),
CAM+CAM (802.39 m/z), CAM+CAM+Diox (818.39 m/z), CAM+Diox (789.87 m/z),
CAM+Triox (797.87 m/z), CAM+Cys→DHA (756.88 m/z), Diox+Triox (785.35 m/z),
Triox+Cys→DHA (752.36 m/z), and Bridge (744.36 m/z) forms. At 1 mM and 20 mM
H2O2, no change in detectable N-terminal species occurs.
We report the subsequent quantitation of each detectable DmTrxR N-terminal
redox center modification in Table 14 and graph the results in Figure 14. Our data
reveals that DmTrxR’s N-terminal redox site initially exhibits 60% Reduced species,
35% Bridge species, and 5% Hyperoxidized species in the absence of H2O2. At 1 mM
H2O2, we detect the N-terminal redox center as 46% Reduced species, 47% Bridge
species, and 7% Hyperoxidized species. At 20 mM H2O2, we see 26% Reduced species,
71% Bridge species, and 3% Hyperoxidized species. Our data shows that between 0 mM
and 20 mM H2O2, there is a 34% decrease in Reduced species, a 31% increase in Bridge
species, and a 4% decrease in Hyperoxidized species.
Table 14. DmTrxR N-terminal redox center response to H2O2 knockdown in the presence
of 50 µM E. coli Trx.
WGLGGTCVNVGCIPK

0 mM H2O2

1 mM H2O2 20 mM H2O2

Reduced

60%

46%

26%

-34%

Bridge

35%

47%

71%

+31%

Hyperoxidized

5%

7%

3%

+4%

43

Δ0→20 (%)

Figure 14. DmTrxR N-terminal redox center response to H2O2 in the presence of 50 µM
E. coli Trx. Change in percentage of Bridge (blue), Reduced (orange), and Hyperoxidized
(grey) species shown in the presence of 0, 1, and 20 mM H2O2. Error bars show standard
deviation.

In the presence of E. coli Trx before the addition of H2O2, DmTrxR’s C-terminal
peptide SGLDPTPASCCS491 occupies the Reduced (1137.46 m/z), CAM+CAM (1251.50
m/z), CAM+CAM+Diox (1283.50 m/z), CAM+CAM+Triox (1299.50 m/z), CAM+Diox
(1226.47 m/z), CAM+Triox (1242.46 m/z), CAM+Cys→DHA (1160.49 m/z),
Diox+Triox (1217.43 m/z), Triox+Triox (1233.42 m/z), and Bridge (1135.44 m/z) forms.
Following the addition of 1 mM H2O2, we do not detect any additional species. As with
the N-terminal redox center, addition of 20 mM H2O2results in the detection of the Cterminal Triox+Triox (1233.42 m/z) modification.
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We report quantitative data on DmTrxR’s C-terminal redox center in Table 15
and graph the resulting data in Figure 15. In the absence of H2O2, DmTrxR’s C-terminal
redox center exhibits 45% Reduced species, 54% Bridge species, and 1% Hyperoxidized
species. At 1 mM H2O2, we detect 33% Reduced species, 66% Bridge species, and 1%
Hyperoxidized species. At 20 mM H2O2, our data shows 10% Reduced species, 82%
Bridge species, and 8% Hyperoxidized species. Between 0 mM and 20 mM H2O2, we see
a 25% decrease in Reduced species, a 28% increase in Bridge species, and a 7% increase
in Hyperoxidized species.
Table 15. DmTrxR C-terminal redox center response to H2O2 knockdown in the presence
of 50 µM E. coli Trx.
SLGDPTPASCCS

0 mM H2O2

1 mM H2O2 20 mM H2O2

Reduced

45%

33%

10%

-25%

Bridge

54%

66%

82%

+28%

Hyperoxidized

1%

1%

8%

+7%
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Figure 15. DmTrxR C-terminal redox center response to H2O2 in the presence of 50 µM
E. coli Trx. Change in percentage of Bridge (blue), Reduced (orange), and Hyperoxidized
(grey) species shown in the presence of 0, 1, and 20 mM H2O2. Error bars show the
standard deviation.

2.3.5 Detection of mTrxR redox centers in the presence of E. coli Trx
In the presence of E. coli Trx and H2O2, we detect mTrxR’s N-terminal redox
peptide CAM+Red (780.88 m/z), CAM+CAM (809.40 m/z), CAM+CAM+Diox (825.40
m/z), CAM+Diox (796.88 m/z), CAM+Cys→DHA (763.89 m/z), and Bridge (751.37
m/z) forms. At 1 and 20 mM H2O2, no change in detectable N-terminal species occurs.
We report the subsequent quantitation of each detectable mTrxR N-terminal redox
center modification in Table 16 and graph the resulting data in Figure 16. Our data
reveals that mTrxR’s N-terminal redox site initially exhibits 27% Reduced species, 70%
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Bridge species, and 3% Hyperoxidized species in the absence of H2O2. At 1 mM H2O2,
we detect the N-terminal redox center as 19% Reduced species, 77% Bridge species, and
4% Hyperoxidized species. At 20 mM H2O2, we see 20% Reduced species, 73% Bridge
species, and 7% Hyperoxidized species. Our data shows that between 0 mM and 20 mM
H2O2, there is a 7% decrease in Reduced species, a 4% increase in Bridge species, and a
4% increase in Hyperoxidized species.
Table 16. mTrxR N-terminal redox center response to H2O2 knockdown in the presence
of 50 µM E. coli Trx.
WGLGGTCVNVGCIPK 0 mM H2O2

1 mM H2O2 20 mM H2O2

Δ0→20 (%)

Reduced

27%

19%

20%

-7%

Bridge

69%

77%

73%

+4%

Hyperoxidized

3%

4%

7%

+4%
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Figure 16. mTrxR N-terminal redox center response to H2O2 in the presence of 50 µM E.
coli Trx. Change in percentage of Bridge (blue), Reduced (orange), and Hyperoxidized
(grey) species shown in the presence of 0, 1, and 20 mM H2O2. Error bars show the
standard deviation.

Without the addition of H2O2, we detect mTrxR’s C-terminal peptide
SGLEPTVTGCUG491 in the CAM+CAM (1285.46 m/z), CAM+CAM+Diox (1317.46
m/z), CAM+Diox (1260.43 m/z), CAM+Triox (1276.42 m/z), CAM+Cys→DHA
(1194.45 m/z), CAM+Sec→DHA (1146.51 m/z), and Bridge (1169.40 m/z) forms.
Following the addition of 1 mM or 20 mM H2O2, we do not detect any additional species.
We report quantitative data on mTrxR’s C-terminal redox center in Table 17 and
graph the resulting data in Figure 17. In the absence of H2O2, mTrxR’s C-terminal redox
center exhibits 22% Reduced species, 74% Bridge species, and 4% Hyperoxidized
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species. At 1 mM H2O2, we detect 17% Reduced species, 79% Bridge species, and 4%
Hyperoxidized species. At 20 mM H2O2, our data shows 21% Reduced species, 51%
Bridge species, and 28% Hyperoxidized species. Between 0 mM and 20 mM H2O2, we
see a 1% decrease in Reduced species, a 23% decrease in Bridge species, and a 24%
increase in Hyperoxidized species.
Table 17. mTrxR C-terminal redox center response to H2O2 knockdown in the presence
of 50 µM E. coli Trx.
SLGEPTVTGCUG

0 mM H2O2

1 mM H2O2 20 mM H2O2

Reduced

22%

17%

21%

-1%

Bridge

74%

79%

51%

-23%

Hyperoxidized

4%

4%

28%

+24%
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Figure 17. mTrxR C-terminal redox center response to H2O2 in the presence of 50 µM E.
coli Trx. Change in percentage of Bridge (blue), Reduced (orange), and Hyperoxidized
(grey) species shown in the presence of 0, 1, and 20 mM H2O2. Error bars show the
standard deviation.

2.4 CONCLUSIONS
There are two goals of this thesis research: 1) to demonstrate superior resistance
to oxidation-induced inactivation by the selenoenzyme mTrxR compared to its Cysortholog DmTrxR, and 2) to provide a biophysical basis for understanding the
evolutionary advantage of selenium-incorporation for redox biochemistry. For the former
aim, spectrophotometric assays point to distinct responses of Sec-containing mTrxR and
Cys-containing DmTrxR to increasing concentrations of oxidant. Our findings support
previous conclusions that Sec-TrxRs retain a higher percentage of Trx reductase activity
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than Cys-TrxRs under the same oxidizing conditions. While this conclusion agrees with
previous reports, thorough MS analysis enables us to formulate a new hypothesis
regarding the biophysical basis for this phenomenon.
Previous MS analysis of the selenoprotein GPX by Conrad et al. reports a 31-fold
increase in oxidized Cys-containing redox center species in their Sec46→Cys46 mutant 64.
In conjunction with marked resistance to oxidation-induced ferroptosis in cells exhibiting
the Sec-containing wild-type enzyme, Conrad hypothesizes that H2O2 inactivates the Cys
mutant of GPX because of increased sensitivity to hyperoxidation. Conrad concludes that
this sensitivity to hyperoxidation results from replacing selenium-containing Sec with
sulfur-containing Cys in the redox center. However, Conrad does not provide substantial
MS analysis to demonstrate the extent of hyperoxidation in the wildtype enzyme for
comparison. Interestingly, our findings suggest that Sec-containing species see a more
significant increase in hyperoxidation in a Sec-containing redox center than in structures
only containing Cys.
A shortcoming of the Conrad study’s conclusions, we believe, is the significance
he attributes to the fold-change detected for Hyperoxidized species. Despite a 31-fold
increase in Hyperoxidized Cys-GPX species, Conrad provides no evidence to support
possible physiological effects resulting from changes in the total GPX enzyme
population. In our findings, basal Hyperoxidized species comprise only a minor
percentage of the total detected species, thus, even a sizeable fold-change does not
necessarily correspond to any biologically or statistically significant change in the
percentage of hyperoxidized species. For this reason, we believe it much more
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informative to look at the percent change in hyperoxidized species relative to the total
population of species detected for each redox center to explain biophysical changes that
impede an enzyme’s mechanism.
Additionally, our methodology includes the quantitation of other mechanistically
relevant species and allows for us to make inferences on trends affecting our enzyme
populations. However, one caveat to our method is the absence of internal standards for
quantitation. As such, we cannot account for differences in the ionization efficiencies of
each of our many unique species during MS analysis. Without correcting for differences
in ionization efficiencies, we cannot rule out bias in the quantitation of individual peptide
species’ abundances. However, we believe the general trends we observe to be valid and
indicative of physiologically relevant changes impacting TrxR’s reductase activity.
Based on our findings, we hypothesize that under highly oxidizing conditions, Sec
enables superior resistance to oxidation-induced inactivation because selenium possesses
the ability to interconvert rapidly between its Reduced species and oxidized Bridge
species. Thermodynamic and kinetic favorability of selenol/diselenide exchange, as
Pleasants et al. report, enables Sec to rapidly cycle between the selenylsulfide bridge and
the reactive reduced selenol form. Since selenylsulfide Bridge species are mostly
impervious to oxidation, increasing selenylsulfide bridge formation serves to protect the
selenoenzyme from more extensive hyperoxidation and minimizes oxidation-induced
inactivation. The dual cysteine residues in DmTrxR’s C-terminal redox center, on the
other hand, become less reduced in the presence of increasing oxidant favoring the
disulfide bridge form instead. Accordingly, conversion to the disulfide bridge hinders
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DmTrxR’s ability to cycle back to the reduced thiol form due to a significantly lower
thiol/disulfide exchange rate. Thus, as more disulfide Bridge species form in the presence
of oxidant, DmTrxR’s ability to reduce substrate also decreases, causing a loss of
reductase activity. We observe that even in the absence of significant percentage changes
of hyperoxidized species, exposure to hydrogen peroxide causes a decrease in the
successful reduction of DmTrxR’s N-terminal redox center by NADPH, the reduction of
its C-terminal redox center by the N-terminal redox center, and the reduction of available
Trx substrate by the C-terminal redox center.
When examining the response of both mTrxR’s and DmTrxR’s N-terminal redox
centers, it is evident that the introduction of increasing H2O2 does not significantly impact
the percentage of mTrxR’s Reduced, Bridge, and Hyperoxidized species. Under the same
conditions, DmTrxR exhibits a significant loss of Reduced species and an increase in
Bridge species. These findings show that H2O2 does not significantly hyperoxidize
mTrxR’s N-terminal redox nor does its ability to reduce the C-terminal redox center
change significantly. A maintained reductive ability is consistent with the preservation of
mTrxR reductase activity seen in our activity assays. We believe the slight loss of
enzyme activity we observe in the spectrophotometric data is independent of the Nterminal redox center. While not significantly hyperoxidized by H2O2, DmTrxR’s Trx
reductase activity decreases, resulting from a diminished ability to reduce the C-terminal
redox center and available substrate due to increased oxidation back to Bridge caused by
oxidation by H2O2.
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Before adding reducible substrate, analysis of both TrxR enzymes’ C-terminal
redox centers reveals different initial reductive abilities and responses to increasing
oxidant. Without hydrogen peroxide, we detect the mTrxR C-terminal redox center
almost exclusively in the Reduced state, consistent with mTrxR’s N-terminal redox
center (see Figure 18). A highly reduced C-terminal redox center indicates a high initial
reductive ability, enabling the eventual reduction of substrate. Once reduced by the Nterminal redox center, the mTrxR’s C-terminal redox center becomes very reactive due to
the facile formation of a selenolate anion at physiological pH. Without substrate to
reduce, the Sec-containing C-terminal redox center is highly susceptible to
hyperoxidation, resulting in a significant decrease of Reduced species and an increase of
Hyperoxidized species with H2O2 present. However, due to selenium’s robust
electrophilic and nucleophilic character, a portion of oxidized species converts to the
selenylsulfide Bridge form. As mentioned previously, we suspect that the formation of
the selenylsulfide Bridge does not result in a loss of reductase activity.

Figure 18. Basal mTrxR N- and C-terminal redox center Reduced species in the absence
of E. coli Trx. High percentages of Reduced species indicate high reductive abilities. The
remaining percentages include oxidized Bridge and Hyperoxidized species.
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Unlike mTrxR, DmTrxR’s C-terminal redox center demonstrates a significantly
lower reductive ability signified by less than 30% of total species initially in the Reduced
form (see Figure 19). From this observation, we conclude that DmTrxR’s N-terminal
redox center does not efficiently reduce its C-terminal redox under our reaction
conditions. Exhibiting a lower percentage of Reduced species also explains why there
was a minor increase in the percentage of Hyperoxidized species when adding H2O2 to
DmTrxR relative to the Sec-enzyme. Under these conditions, most species remain in the
oxidized disulfide Bridge species and are protected from hyperoxidation. However,
unlike mTrxR’s response, H2O2 causes previously reduced species to become
Hyperoxidized without causing a change in the percentage of Bridge species. DmTrxR’s
Reduced species do not readily convert back to Bridge species when oxidant is present.
Thus, the loss of C-terminal redox center Reduced species and gain of Hyperoxidized
species causes an irreversible loss of DmTrxR reductase activity.

Figure 19. Basal DmTrxR N- and C-terminal redox center reduced species in the absence
of E. coli Trx. Medium/low percentages of Reduced species indicate poor reductive
abilities. The remaining percentages include oxidized Bridge and Hyperoxidized species.
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After adding 50 uM E. Coli Trx, reducing substrate disulfide bonds results in a
shift from the reduced state to the oxidized Bridge state. In the absence of H2O2, we find
the mTrxR redox centers predominantly in the Bridge state, approximately 60% more
than without Trx, signifying a substantial reduction of available Trx (see Figure 20). As
was the case without Trx, the subsequent introduction of H2O2 at 1 mM and 20 mM does
not drastically alter the percentage of mTrxR N-terminal redox center species in the
Reduced, Bridge, and Hyperoxidized states. These findings further support the notion that
oxidants do not interact with mTrxR’s N-terminal redox frequently. In DmTrxR’s Nterminal redox center, the percentages of Reduced, Bridge, and Hyperoxidized species
closely resemble those in the control samples without Trx. Thus, Trx does not
significantly alter the N-terminal redox center’s reductive ability. In the same vein,
changes in response to increasing oxidant concentration follow similar trends samples
without Trx, indicating a drop in reductive ability and causing a loss of reductase activity.

Figure 20. Basal mTrxR N- and C-terminal redox center Reduced and Bridge species in
the presence of 50 µM E. coli Trx. Both redox centers heavily favor the formation of
Bridge species indicating the successful reduction of Trx substrate. The remaining
percentages include Hyperoxidized species.
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Our data show that introducing E. coli Trx substrate before oxidation causes
mTrxR’s C-terminal redox center to shift to the selenylsulfide Bridge with a minor
proportion remaining in the Reduced form (see Figure 21). This initial shift relative to
species we detect in the absence of Trx is a direct result of the enzyme’s reductase
activity when the substrate is present. With only ~20% of its species in the Reduced
form, mTrxR’s C-terminal also does not exhibit a significant percentage change with
H2O2 present, a strong contrast to its response without Trx. The DmTrxR C-terminal
redox center exhibits a significant decrease in Reduced species, instead favoring the
disulfide Bridge. As was the case for samples we analyze under assay conditions, the loss
of Reduced DmTrxR C-term corresponds to a loss of reductase activity in the presence of
H2O2.

Figure 21. Basal DmTrxR N- and C-terminal redox center Reduced and Bridge species
in the presence of 50 µM E. coli Trx. N-terminal redox center favors Reduced species
while C-terminal redox center slightly favors the formation of Bridge species indicating
the successful reduction of Trx substrate. The remaining percentages include
Hyperoxidized species.

In summary, selenocysteine present in mTrxR confers resistance to oxidationinduced inactivation, enabling it to retain more of its reductase activity than the D.
melanogaster Cys-ortholog. MS analysis reveals that the retention of TrxR’s two redox
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center’s reductive abilities rather than the avoidance of hyperoxidation is responsible for
retained Trx reductase activity. The robust nucleophilic and electrophilic character of
selenium enables mTrxR C-terminal redox centers to quickly cycle between its Reduced
form and its oxidized selenylsulfide Bridge form. The Bridge state protects the enzyme
from hyperoxidation by oxidants like H2O2 but does not cause a significant loss of
enzymatic activity. Superior retention of reductive abilities provides a unique
evolutionary advantage over analogous redox structures in Cys-ortholog and justifies the
bioenergetic costs we associate with Sec incorporation into selenoproteins such as
thioredoxin reductase.
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APPENDICES
A. ABBREVIATIONS
ACN, acetonitrile; AmBic, ammonium bicarbonate; amu, atomic mass unit; ASK1,
apoptosis signal-regulating kinase 1; ATP, adenosine triphosphate; CAM,
carbamidomethyl; CUG, trimer Cys-Sec-Gly; Cys, cysteine; Cys→DHA, cysteine to
dehydroalanine; D. melanogaster, Drosophila melanogaster; ddI H2O, deionized water;
DHA, dehydroalanine; Diox, sulfinic or seleninic acid; DmTrxR, Drosophila
melanogaster thioredoxin reductase; DsbA, disulfide bond protein A; E. coli, Escherichia
coli; EDTA, ethylenediaminetetraacetic acid; EFSec, selenocysteine elongation factor;
EIC, extracted ion chromatogram; ESI, electrospray ionization; FA, formic acid;
FAD/FADH2, flavin adenine dinucleotide; GCUG, tetrapeptide Gly-Cys-Sec-Gly; GPX,
glutathione peroxidase; H-, hydride; H2O2, hydrogen peroxide; HOBr, hypobromous acid;
HOCl, hypochlrorous acid; HOSCN, hypothocyanous acid; kcat, catalytic rate constant;
KM, Michaelis-Menten constant; KP, potassium phosphate LC, liquid chromatography;
LCMS, liquid chromatography-mass spectrometry; m/z, mass per charge; Met,
methionine; mRNA, messenger ribonucleic acid; MS, mass spectrometry; MsrB1,
methionine-R-sulfoxide reductase 1B; mTrxR, mammalian thioredoxin;
NADP+/NADPH, nicotinamide adenine dinucleotide phosphate; NHE, normal hydrogen
electrode; nm, nanometer; NO3-, peroxynitrite; ·OH, hydroxy radical; Ox, sulfenic or
selenenic acid; pg, picogram; pH, potential of hydrogen; pKa, acid dissociation constant;
pm, picometer; PTP1B, protein tyrosine phosphatase 1B; Red, reduced; RES, reactive
electrophile species; RNR, ribonucleotide reductase; RNS, reactive nitrogen species;
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ROS, reactive oxygen species; R-Se-, selenolate anion; R-SeH, selenol; R-SeO2H,
seleninic acid; R-SeO3H, selenonic acid; R-SeOH, selenenic acid; R-SH, thiol; R-SO2H,
sulfinic acid; R-SO3H, sulfonic acid; R-SOH, sulfenic acid; S, sulfur; SBP2, SECIS
binding protein-2; SCCS, tetrapeptide Ser-Cys-Cys-Ser; Se, selenium; Sec,
selenocysteine; Sec→DHA, selenocysteine to dehydroalanine; SECIS, selenocysteine
insertion sequence; SeO32-, selenite; SERS, seryl-tRNA synthase; SO32-, sulfite; SPS2,
selenophosphate synthase 2; TFA; trifluoroacetic acid; Triox, sulfonic or selenonic acid;
tRNA, transfer ribonucleic acid; Trx, thioredoxin; TrxR, thioredoxin reductase; Tyr,
tyrosine; UGA, "opal" stop codon, uracil-guanadine-adenine; UV, ultraviolet; VIS,
visible.
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B. MASS SPECTRA AND CHEMICAL STRUCTURES OF
PEPTIDE SPECIES DETECTED BY MS

DmTrxR N-terminal redox center-containing peptide WGVGGTCNVGCIPK “Reduced”.
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DmTrxR N-terminal redox center-containing peptide WGVGGTCNVGCIPK
“CAM+Red”.

68

DmTrxR N-terminal redox center-containing peptide WGVGGTCNVGCIPK
“CAM+CAM”.

69

DmTrxR N-terminal redox center-containing peptide WGVGGTCNVGCIPK
“CAM+Diox”.

70

DmTrxR N-terminal redox center-containing peptide WGVGGTCNVGCIPK
“CAM+Triox”.

71

DmTrxR N-terminal redox center-containing peptide WGVGGTCNVGCIPK
“Diox+Triox”.

72

DmTrxR N-terminal redox center-containing peptide WGVGGTCNVGCIPK
“Triox+Cys→DHA”.

73

DmTrxR N-terminal redox center-containing peptide WGVGGTCNVGCIPK “Bridge”.
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DmTrxR C-terminal redox center-containing peptide SGLDPTPASCCS “CAM+CAM”.

75

DmTrxR C-terminal redox center-containing peptide SGLDPTPASCCS “CAM+Diox”.

76

DmTrxR C-terminal redox center-containing peptide SGLDPTPASCCS “CAM+Triox”.

77

DmTrxR C-terminal redox center-containing peptide SGLDPTPASCCS
“CAM+Cys→DHA”.

78

DmTrxR C-terminal redox center-containing peptide SGLDPTPASCCS “Triox+Triox”.

79

DmTrxR C-terminal redox center-containing peptide SGLDPTPASCCS
“Triox+Cys→DHA”.

80

DmTrxR C-terminal redox center-containing peptide SGLDPTPASCCS “Bridge”.
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mTrxR N-terminal redox center-containing peptide WGLGGTCVNVGCIPK
“CAM+Red”.

82

mTrxR N-terminal redox center-containing peptide WGLGGTCVNVGCIPK
“CAM+CAM”.

83

mTrxR N-terminal redox center-containing peptide WGLGGTCVNVGCIPK
“CAM+Diox”.

84

mTrxR N-terminal redox center-containing peptide WGLGGTCVNVGCIPK
“CAM+Triox”.

85

mTrxR N-terminal redox center-containing peptide WGLGGTCVNVGCIPK
“CAM+Cys→DHA”.

86

mTrxR N-terminal redox center-containing peptide WGLGGTCVNVGCIPK
“Diox+Triox”.

87

mTrxR N-terminal redox center-containing peptide WGLGGTCVNVGCIPK
“Triox+Cys→DHA”.

88

mTrxR N-terminal redox center-containing peptide WGLGGTCVNVGCIPK “Bridge”.
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mTrxR C-terminal redox center-containing peptide SGLEPTVTGCUG “CAM+CAM”.

90

mTrxR C-terminal redox center-containing peptide SGLEPTVTGCUG “CAM+Diox”.

91

mTrxR C-terminal redox center-containing peptide SGLEPTVTGCUG “CAM+Triox”.

92

mTrxR C-terminal redox center-containing peptide SGLEPTVTGCUG
“CAM+Cys→DHA”.

93

mTrxR C-terminal redox center-containing peptide SGLEPTVTGCUG
“CAM+Sec→DHA”.

94

mTrxR C-terminal redox center-containing peptide SGLEPTVTGCUG “Bridge”.
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